Literature DB >> 24589843

[Individualized stem cell therapy].

W-H Zimmermann1.   

Abstract

Stem cells are attributed with having a great potential in regenerative medicine. Pluripotent stem cells are particularly interesting because they can be multiplied indefinitely and also differentiated under defined conditions. Currently, cardiomyocytes can be differentiated very effectively from pluripotent stem cells, making the former an attractive starting material for cardiac disease modeling in a culture dish (patient in a dish) and cell based-therapy in heart failure. The rapid biotechnological advances made in recent years now enable these concepts to be translated into clinical applications.

Entities:  

Mesh:

Year:  2014        PMID: 24589843     DOI: 10.1007/s00059-014-4073-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  19 in total

1.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

2.  Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.

Authors:  Hiroshi Naito; Ivan Melnychenko; Michael Didié; Karin Schneiderbanger; Pia Schubert; Stephan Rosenkranz; Thomas Eschenhagen; Wolfram-Hubertus Zimmermann
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

4.  Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.

Authors:  Alexander G Bick; Jason Flannick; Kaoru Ito; Susan Cheng; Ramachandran S Vasan; Michael G Parfenov; Daniel S Herman; Steven R DePalma; Namrata Gupta; Stacey B Gabriel; Birgit H Funke; Heidi L Rehm; Emelia J Benjamin; Jayashri Aragam; Herman A Taylor; Ervin R Fox; Christopher Newton-Cheh; Sekar Kathiresan; Christopher J O'Donnell; James G Wilson; David M Altshuler; Joel N Hirschhorn; J G Seidman; Christine Seidman
Journal:  Am J Hum Genet       Date:  2012-09-07       Impact factor: 11.025

5.  Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle.

Authors:  Poh Loong Soong; Malte Tiburcy; Wolfram-Hubertus Zimmermann
Journal:  Curr Protoc Cell Biol       Date:  2012-06

Review 6.  Derivation and potential applications of human embryonic stem cells.

Authors:  Lior Gepstein
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

7.  Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.

Authors:  Coby Carlson; Chad Koonce; Natsuyo Aoyama; Shannon Einhorn; Steve Fiene; Arne Thompson; Brad Swanson; Blake Anson; Steven Kattman
Journal:  J Biomol Screen       Date:  2013-09-26

8.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.

Authors:  Sebastian Schaaf; Aya Shibamiya; Marco Mewe; Alexandra Eder; Andrea Stöhr; Marc N Hirt; Thomas Rau; Wolfram-Hubertus Zimmermann; Lenard Conradi; Thomas Eschenhagen; Arne Hansen
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.